Navigation Links
PharmAthene Submits Legal Brief in Response to SIGA Technologies' Motion for Reargument
Date:10/13/2011

ANNAPOLIS, Md., Oct. 13, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP) today announced that it has filed its legal brief in response to SIGA Technologies' motion for reargument.  On September 22, 2011 PharmAthene announced that the Delaware Court of Chancery had issued a ruling in its litigation against SIGA and awarded PharmAthene 50% of the net profits over 10 years from all sales of ST-246 and related products after SIGA receives the first $40 million in net profits.

The defendant's motion for reargument asserts, among other things, that the Court erred in its application of law in awarding an equitable payment stream to PharmAthene.  In its legal brief, PharmAthene outlines specific examples in Delaware case law supporting Vice Chancellor Parson's use of a constructive trust as an appropriate equitable remedy.  

"We look forward to Judge Parson's decision on the motion and next steps," commented Eric I. Richman, President and Chief Executive Officer.  "If the court denies the motion, the parties will have 20 days from that date to submit a proposed form of final judgment, following which the Court will render its final order."

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Valortim® - a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia® - a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents

In addition,
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PharmAthene to Webcast its Third Quarter Conference Call on November 13, 2007 at 4:30 P.M. Eastern Time
2. PharmAthenes Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimers Disease
3. PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop
4. PharmAthene Initiates Phase I Clinical Trial of Nerve Agent Bioscavenger Protexia(R)
5. PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program
6. PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA
7. PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)
8. PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop
9. PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop
10. PharmAthene Develops Thermostable Lyophilized rPA Anthrax Vaccine Under a Challenge Grant From the National Institutes of Health
11. PharmAthene Presents New Data for Lyophilized rPA Anthrax Vaccine Showing Enhanced Immunogenicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... WAYNE, Pa. , July 1, 2015 /PRNewswire/ ... a fully integrated specialty pharmaceutical company focused on ... announced that Bob Radie , president and ... upcoming conferences this summer. He will provide an ... (ketorolac tromethamine) Nasal Spray, approved product ...
(Date:7/1/2015)... 2015 New exchange plan enrollees spent less ... to the same time a year ago, according to ... ESRX ) Exchange Pulse™ report, released today. ... number of new exchange plan enrollees who used at ... first quarter of 2015. However, when evaluating exchange plan ...
(Date:7/1/2015)... July 1, 2015 The Haselmeier ... Board. Mr. Gert Weber has been nominated ... as Chief Executive Officer (CEO) of the ... st , 2015. Mr. Weber brings more than 20 ... and has filled various executive management positions, the last ...
Breaking Medicine Technology:Egalet to Present at Upcoming Conferences This Summer 2Egalet to Present at Upcoming Conferences This Summer 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 2Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 3Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 4Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends 5Haselmeier Group Announces the Extension and Reorganization of its Executive Board 2
... HOUSTON, Nov. 11 The Houston trial law firm ... the makers of pain pumps and related medications based on claims ... are causing irreversible shoulder damage among patients. , Currently, the attorneys ... people who received pain pumps to manage pain following shoulder surgery. ...
... 11 The Endovascular Forum (EVF), an IC Sciences company, ... and Technologies (GEST), and the launch of a dynamic online ... with the GEST mission and aim of bringing practitioners the ... of new materials and devices, their results, relevance for patient ...
Cached Medicine Technology:Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 2Arnold & Itkin Announces Lawsuits Over Defective Pain Pumps 3Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care 2Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care 3
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court overseeing a ... has granted the Defendants’ Motion for Summary Judgment. According to an Order issued ... the Court rejected the Plaintiff’s assertion that one manufacturer can be held ...
(Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, a leading ... fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held at the ... to supporting S4L in its mission to provide free quality orthodontic care to ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich , ... March 6th - 8th, the 2016 meeting will be held at the Westin Galleria ... nasal surgery through the most modern advancements and updates in rhinoplasty and revision ...
(Date:7/1/2015)... ... ... The 28th annual Charity Horse Show hosted by the Mid-South Horse Show ... in Pugh Bourne Park, 343 Oakfield Road. The event will again benefit Youth Town. ... a silent auction and concessions. , Horses and riders from around the country will ...
(Date:7/1/2015)... ... 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor of Science ... earning a Master’s degree in Microbiology. He graduated from the University of Florida College ... the Florida Dental Association and the Academy of General Dentistry. Dr. Williams was born ...
Breaking Medicine News(10 mins):Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2
... containing benadryl linked to slowed thinking, delirium in ... News) --Older people taking common over-the-counter drugs for ... increase their risk for cognitive impairment, including delirium, ... include Benadryl, Dramamine, Excedrin PM, Nytol, Sominex, Tylenol ...
... healthcare IT company by revenue , , HATBORO, Pa., June ... IFLG ), a leading technology provider of enterprise mobility solutions for ... been named to Healthcare Informatics , ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20071101/NETH165LOGO ...
... Programs Give Seniors Helpful Solutions , , HOUSTON, ... nation,s largest non-profit organization for seniors, with over 500,000 ... Support & Financial and Retirement Planning. , , ... of resources to SCB members, with the goal of ...
... ... based clinic - The London Clinic. The contract marks the world,s first live site of ... ... leading provider of clinical workflow and integration technology for the health care sector world-wide, has ...
... Best ... minded individual. , ... London, England (PRWEB) June 5, 2009 -- Best Pills Inc is proud to announce ... ,The site is unique in its offering of popularly prescribed "discreet" prescription drugs ...
... PROVO, Utah, June 4 Nu Skin Enterprises, Inc. (NYSE: ... has declared a quarterly dividend of $0.115 per share, which ... record on June 15, 2009. , , The ... has been demonstrating its tradition of innovation through its comprehensive ...
Cached Medicine News:Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 2Health News:Some OTC Sleep, Cold Meds Could Harm Aging Brain 3Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 2Health News:InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World 3Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:Orion Health Live at Harley Street Clinic 2Health News:Orion Health Live at Harley Street Clinic 3Health News:Bestpills Launchs its New Online Pharmacy 2
Fixed smooth rod which slides on skin. Designated most popular model or size....
... blade. 17 mm wide blade. ... inches. Note: Has Marcks attachment ... to any thickness up to ... thicker grafts or split graft. ...
6 mm x 23 mm blunt, double-edged blade. Flat handle....
Double-ended. Blades set at 45 and 90 degrees. Hexagonal handle....
Medicine Products: